
Structural Interventional Cardiologist #TAVR #Mitraclip #LAA closure #PERT #PFO #CHIP #radialfirst #MGHHeartHealth trained
Louisville, KY
Joined June 2010
- Tweets825
- Following945
- Followers2.8K
- Likes1.1K
Pinned Tweet
Palliative percutaneous pericardial window @mnyoung1 @KHERA_MD @rashaalbawardy @SammyElmariahMD – at Boston, MA
Vikas Singh MD FACC FSCAI retweeted
MitraClip vs PASCAL - the answer is clear! ;) @ryankaple @CorsVascAtShore @CorsAtTheShore @SABOURETCardio @CardiacConsult @rzakir12 @RajTayalMD @drmkmittal @pkothapalliMD @timir_paul
Vikas Singh MD FACC FSCAI retweeted
Congratulations to @krosenfieldMD! Master Operator, Great Teacher and Fantastic Human!! @mnyoung1 @EricSecemskyMD @MGHHeartHealth @crfheart @SCAI
📣 Announcing the #TCT2025 Master Operator Award recipient: Dr. Kenneth Rosenfield (@krosenfieldMD)! 🏆
With 35+ years of dedication to advancing patient care, Dr. Rosenfield has been a driving force in endovascular therapy — pioneering innovative techniques, shaping transformative technologies, and mentoring the next generation of leaders in #interventionalcardiology. tctconference.com/master-ope…
Join us in San Francisco as we celebrate his remarkable contributions to the field! 👏 tctconference.com/register
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @georgedangas @jgranadacrf @MartyBLeon @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @TCTConference @TCTMD
Senior investigators, academic cardiologists take note. Promote your fellows/residents/students. Let them shine! That’s real mentorship.
Also kudos to @rallamee very few senior investigators would have given the opportunity to their fellow to present the study at the AHA. She also had her other three Research fellows sitting in the same room as the Interview so they could get exposure to interviews by Press.
This is what more senior investigators should be doing - investing in the next generation
2
11
672
Vikas Singh MD FACC FSCAI retweeted
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events: @JACCJournals
*** Great - this is what @AHAScience recommended for older higher risk patients: @MichaelGNanna
25-point summary in am report: (they are short sentences 😱)
👇👇👇
Vikas Singh MD FACC FSCAI retweeted
In summary, the pharmacologic Rx for HFpEF starts with SGLT2i:
+/- loop diuretics
+/- MRA
+/- ARNI
+/- ARB (cannot take ARNI)
Will continue with thread # 6 starting from #49: Non pharamcologic Rx and Mx of multiple chronic conditions.
Sorry for many threads.
Vikas Singh MD FACC FSCAI retweeted
Looking to get more involved with @SCAI?
Apply to be a mentee or a mentor ➡️ scai.org/membership/professi…
@SVRaoMD @SrihariNaiduMD @HenrytTimothy @mirvatalasnag @DrJayMohan @DPtheNP @Drroxmehran @georgedangas @JVargheseMD
Vikas Singh MD FACC FSCAI retweeted
The drug of the day is Tong Xin Lou, winner in CTS-AMI at #AHA with a 36% relative risk reduction in MACCE at 30 days in STEMI patients. A capsule includes ginseng, leeches, scorpions, red peony root, three types of earthworms, sandalwood, frankincense, suan zao ren and borneol.
Vikas Singh MD FACC FSCAI retweeted
Mechanical thrombectomy using FlowTriever System for intermediate- to high-risk PE patients who don't fit conventional criteria for intervention was safe, associated with immediate hemodynamic and symptom benefits, the FLASH registry showed #TCT2022
Vikas Singh MD FACC FSCAI retweeted
#SYMPLICITY HTN-3 trial shows significant ⬇️ in office & 24h ambulatory SBP to 3yrs w/ RDN compared w/ sham, independent of meds! Potential confounding factors may have played a role.. No late emerging complications.. #TCT2022 #LBCT @crfheart @TCTConference @DLBHATTMD #ACCIC
Vikas Singh MD FACC FSCAI retweeted
#TCT2022 Social Media Ambassadors
Vikas Singh MD FACC FSCAI retweeted
RADIANCE II trial shows statistically & clinically significant ⬇️ in daytime ambulatory SBP & 24h nighttime, home, & office SBP w/ endovascular #uRDN compared w/ sham! No MAE at 30d! @ajaykirtane #LBCT #TCT2022 @crfheart @TCTConference @JACCJournals @sahilparikhmd @krosenfieldMD
Vikas Singh MD FACC FSCAI retweeted
#Symplicity HTN 3 year follow-up (and some to 60 mo) results presented at #TCT2022 by @DLBHATTMD. Sustained decrease in blood pressure which improved as time progressed.
@sahilparikhmd @DrMarthaGulati @AnastasiaSMihai
Vikas Singh MD FACC FSCAI retweeted
The PROTECTED TAVR trial showed that routine use of a CEP device does not result in a lower risk of #stroke within 72 hours among patients undergoing transfemoral #TAVR for #vhdAS. Find out more: https://teapawt.net/t.co/2CPSo1LY2K #TCT2022 @DLBHATTMD
Vikas Singh MD FACC FSCAI retweeted
Challenges w/ dev of valves for TMVR!
&
How can future systems achieve universal adoption?
🌟Design adaptable to multiple sizes & anatomical variability
🌟Mechanical performance in real world anatomy
🌟Delivered in low profile high performance catheters
🌟Evolution of imaging
Vikas Singh MD FACC FSCAI retweeted
Follow our #TCT2021 Social Media Ambassadors! With their vast experience and expertise, they’ll help you get a unique perspective on the meeting. ow.ly/yhIB50GCTJn @DrAsifQasim @Hragy @DocSavageTJU @vikmd1026 @poojaotherwise
Vikas Singh MD FACC FSCAI retweeted
Transcatheter edge-to-edge repair (TEER) grew 2014-18 w/ improved outcomes & lower costs & length of stay. Readmission unchanged at 30-day, trend toward increase at 90 & 180 days.
onlinelibrary.wiley.com/doi/…
teapawt.net/ccijournal, facebook.com/ccijournal, instagram.com/ccijournal
The spring tip of CSI detached from the crown while treating a heavily calcified left circ. It happened after 6/7 passes. Has anyone else experienced this issue? @csi360
Vikas Singh MD FACC FSCAI retweeted
VERY RARE complication of #RadialFirst: Noninfectious, sterile abscess/granuloma formation as a reaction to hydrophilic coating of old sheaths.
Recognize this!













































